Seri Surgical Scaffold Support of the Lower Pole of the Breast

NCT ID: NCT02016612

Last Updated: 2018-02-13

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

76 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-10-31

Study Completion Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Will the use of an FDA approved highly purified silk scaffold; Seri Surgical Scaffold help shape and hold the breast up on the chest preventing re-stretching and bottoming out of the breast in breast reduction or augmentation-mastopexy patients? The amount of stretch will be measured manually as well as percent of breast tissue measured with the Canfield Vectra 3-D Imaging system reporting the amount of breast tissue above and below the nipple level.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients having augmentation mastopexy or breast reduction will be informed about Seri Scaffold and allowed to have Seri support included in their surgery or not. If the choose the scaffold will be placed under the skin in the lower pole of the breast as an internal hammock to help take weight off of the breast and potentially help prevent future stretch of the lower pole.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Recurrent Ptosis of the Breast

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Reduction, Mastopexy No Implant, No Seri

Patients undergoing reduction or mastopexy but no implant is used and no Seri Surgical Scaffold support is used

Group Type ACTIVE_COMPARATOR

Seri Surgical Scaffold

Intervention Type DEVICE

An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.

Mastopexy, Implant no Seri Scaffold

Mastopexy with implant, No Seri Surgical Scaffold support is used

Group Type ACTIVE_COMPARATOR

Seri Surgical Scaffold

Intervention Type DEVICE

An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.

Breast Reduction with Seri Support

Patients undergoing breast reduction with the use of Seri Surgical scaffold support

Group Type ACTIVE_COMPARATOR

Seri Surgical Scaffold

Intervention Type DEVICE

An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.

Augmentation Mastopexy, Implant and Seri

Augmentation Mastopexy patients where Seri Surgical scaffold is used

Group Type ACTIVE_COMPARATOR

Seri Surgical Scaffold

Intervention Type DEVICE

An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Seri Surgical Scaffold

An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Seri Seri Scaffold

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Age =\>18 years

* requesting procedure
* No active cancer or infection

Exclusion Criteria

* Known allergy to silk
* Pregnant or lactating
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Allergan Medical

INDUSTRY

Sponsor Role collaborator

Bengtson Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bradley Bengtson, M.D.

Bradley P Bengtson, MD FACS

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bradley P Bengtson, MD

Role: PRINCIPAL_INVESTIGATOR

Bengtson Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bengtson Center for Aesthetics and Plastic Surgery

Grand Rapids, Michigan, United States

Site Status

Center for Aesthetics and Plastic Surgery

Grand Rapids, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

007

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Spectra Breast Implant Study
NCT00981266 WITHDRAWN PHASE3